melior discovery inc private biopharmaceutical company based exton pennsylvania usa company specializes drug repositioning established proprietary phenotypic screening platform uses purpose melior also offers certain contract research organization cro services comprising animal models representing different disease conditions company issued press releases disclosing partnerships pfizer merck co johnson johnson astrazeneca citing use company drug repositioning technology melior discovery also used technology discover drug candidates melior discovery cofounded dr andrew reaume president ceo dr michael saporito vice president investors include cammeby capital group ventureast osage ventures midatlantic angel group march food drug administration fda approved company investigational new drug ind application type diabetes therapeutic candidate company reported licensing partnership bukwang pharmaceutical company initiation clinical trials march june company reported positive results phase clinical study diabetic httpsenwikipediaorgwikimeliordiscovery